Introduction
============

Regulation of the vascular system is essential for tissue growth and homeostasis, and aberrant vascular signalling has been implicated in a vast number of diseases, such as cancer, diabetes, arthritis, macular degeneration and cardiovascular disorders [@b1]. The majority of research examining endothelial function has focused on the effects of secreted growth factors and cytokines such as vascular endothelial growth factor, fibroblast growth factor, transforming growth factor (TGF)β and a host of other molecules on endothelial cell signalling and physiology. Although these factors undoubtedly play a critical role in regulating cardiovascular development, function and disease, a growing number of studies indicate that endothelial physiology, as well as that of many other cell types, is directed by an intimate combination of physical, chemical and biological cues present in the tissue microenvironment [@b2],[@b3]. Over a century ago, physical cues were hypothesized to play important roles in tissue development and there are no better examples in the human body than the deleterious effects of microgravity on bone structure [@b4] and hypertension on cardiovascular function [@b5]. However, almost all organisms have evolved specific structures that are tailored to respond to nano- and macroscale physical forces whereby cells are able to detect and respond to external forces through mechanically induced conformational or organizational changes in cellular molecules, such as stretch-sensitive ion channels, G protein coupled receptors, tyrosine kinase receptors, cadherins and integrins located on the plasma membrane and in cell-to-cell and cell-to-extracellular matrix junctions [@b6].

Over the past decade, a large number of studies have manipulated endothelial tension, compression and shear stress aiming to determine how mimicking blood flow affects endothelial function [@b7]. Despite the progress made in this area, many of the mechanisms regulating how extrinsic mechanical stresses affect endothelial physiology remain unknown, and the implications of such studies are primarily limited to extrapolations of how lumenal blood flow from normal, hypertensive and sclerotic conditions affects endothelial cells. A wealth of primarily qualitative evidence suggests that cell morphology-specific regulation of mechanotransduction is essential for cellular fate decisions such as proliferation, apoptosis, differentiation and quiescence [@b8]--[@b12]. For example, restriction of endothelial cell spreading using micropatterned substrates induces cell cycle arrest and apoptosis [@b8]. Alternatively, cell proliferation increases when cell spreading is allowed, whereas cells preferentially undergo differentiation in a moderately spread state. Endothelial migration is significantly more guided and regulated on narrower adhesive surfaces than on larger ones and geometric cues have been shown to modulate endothelial differentiation [@b13]. Other cells types may show distinct phenotypes solely on morphological alterations. For example, it has been reported that human stem cells can be directed to osteogenic or adipogenic developmental lineages by simply manipulating cell shape and thereby altering cellular mechanics [@b14], although more recent follow-up studies conducted in a separate laboratory suggest that adipogenic potential is not dependent on cell geometry [@b15]. Previously reported data obtained in our laboratory and others indicate that alterations in cell shape and cytoskeletal dynamics are capable of markedly overriding external mitogenic signalling [@b12],[@b16]. This suggests that, as opposed to a model in which cell proliferation, death and differentiation are largely independent of cell shape, these processes are coordinately regulated and modulated by cellular mechanics. Thus, the local differentials in growth factors, biochemistry and internal and external mechanical stress synergize to modulate the specificity that drives tissue heterogeneity during development, normal function and disease.

Cell shape changes have been associated with nuclear shape remodelling [@b11],[@b17]--[@b19]. It has been hypothesized that the transduction of mechanical information through cytoskeletal/nuclear coupling results in alterations that modulate chromosomal architecture and subsequent accession of transcription factors to their target genes [@b20]--[@b24]. Indeed, recent work has demonstrated that large-scale changes in cell shape induce alterations in chromosome condensation leading to marked effects on cell proliferation [@b25]. Thus, distinct cellular morphologies may drive the patterning of unique cytoskeletal architectures that govern global gene expression [@b26]. Despite these findings, it is not known how cell shape and its effects on cytoskeletal structures modulate global transcriptional patterns.

Although the normal surface of arteries is smooth, atherosclerotic arteries are characterized by irregular arrangement of endothelial cells, compromised monolayer integrity, irregular protrusions in the shape of scales or plates, and altered endothelial cell geometry [@b27],[@b28]. Thus an understanding of how endothelial cell shape changes affect cellular function may shed light on the deregulation of endothelial cells during aberrant states such as hypertension, arteriosclerosis and coronary artery disease. In the present study, we examined the global gene expression changes that occur when human coronary artery endothelial cells (HCAECs) are shape and spread restricted by micropatterning into reproducibly unique cellular morphologies that are distinctive in polarization, morphological angularity and actin cytoskeleton patterning. Given the wealth of data suggesting that cell shape and cytoskeletal patterning can alter cellular physiology across a large number of cell types, we specifically investigated whether unique alterations in these cellular properties are capable of modulating global gene expression changes in endothelial cells. Our data demonstrate that geometric restriction induces dramatic alterations in the HCAEC transcriptome, although these changes are independent of the exact cell shape and/or actin orientation assumed by the cell.

Results
=======

Quantitative analysis of cell shape-induced cytoskeletal and nuclear changes in HCAECs
--------------------------------------------------------------------------------------

To determine how cell shape alterations regulate the endothelial transcriptome, we must first utilize a system that manipulates cellular morphology at the same time as consistently maintaining all other growth variables. Accordingly, we seeded HCAECs on collagen I-coated spatially defined micropatterns, allowing cells to adapt to reproducible large (1600 μm^2^) geometric patterns, including a disc, crossbow, H, Y and L ([Fig. 1](#fig01){ref-type="fig"}A). We specifically utilized this cell type because endothelial cells of the coronary artery are constantly exposed to cyclic mechanical changes from blood flow during normal physiological processes and disrupted mechanical changes as a result of abnormal blood flow, cell shape deformation and loss of polarization during coronary artery disease. The size of the micropattern was specifically chosen because we tested micropatterns restricting the cells to either 700 or 1100 μm^2^; however, at these sizes, the cells failed to reproducibly conform to the intended shape (data not shown). Moreover, larger micropatterns would allow multiple cells to attach to one micropattern, thus dramatically affecting reproducibility of cell shape. As a control for nonrestricted morphology, cells were also plated at subconfluent levels on the chip in an area coated in collagen I. These patterns were specifically chosen for their ability to alter cell polarization (because this affects stress fibre architecture and nuclear orientation) [@b25] and the angularity of the cells' morphologies. Disk-shaped cells adopted a round morphology with obtuse cellular edges and random polarization. Crossbow and H-shaped cells exhibit a combination of obtuse and acute edges and become strongly and moderately polarized, respectively. Y- and L-shaped cells were dominated by acute angles, with strong polarization in the Y-shaped cells and no polarization in the L-shaped cells.

![HCAEC growth on micropatterned substrates. (A) Representative bright field images of HCAECs grown on a nonrestrictive collagen I-coated substrate (normal-shaped) or on collagen I-coated micropatterns (Y shape is represented). Although the micropatterned cells were spatially restricted, HCAECs were seeded at low densities in the nonrestricted controls to ensure minimization of cell-to-cell contacts. (B) Representative immunofluorescence (IF) and surface rendering (RF) images of nonrestricted and micropatterned (H, X-bow, disc, L and Y) HCAECs stained for actin (red), phospho-focal adhesion kinase (green) and nuclei (blue).](febs-280-4474-f1){#fig01}

To quantify how endothelial cell shape drives actin cytoskeleton patterning, we performed immunofluorescent confocal imaging of normally-shaped and micropatterned HCAECs labelled with rhodamine-conjugated phalloidin (which stains the actin cytoskeleton), phosphorylated focal adhesion kinase (which stains cellular attachments to the extracellular matrix) and 4′,6-diamidino-2-phenylindole (DAPI) (which highlights the nucleus) ([Fig. 1](#fig01){ref-type="fig"}B). For a full understanding of the quantitative differences in the actin cytoskeletal orientation of each immunofluorescent image, we implemented algorithms to separate the structures of interest from the remainder of the image, thus allowing us to describe the image quantitatively rather than using standard qualitative methods. Accordingly, we employed techniques for linear feature extraction to segment and obtain orientation and length of the actin fibres from each image. The techniques included preprocessing the images to enhance foreground elements, actin fibre detection using [fiberscore]{.smallcaps} [@b29] and filtering including thresholding and mathematical morphology ([Fig. 2](#fig02){ref-type="fig"}). [Figure 2](#fig02){ref-type="fig"}B provides a more suitable input image to [fiberscore]{.smallcaps} for detection because the actin fibres are brighter and display higher contrast. [Figure 2](#fig02){ref-type="fig"}C,D shows the correlation and orientation outputs of [fiberscore]{.smallcaps} and is used for further analysis of length and orientation, respectively.

![Cytoskeletal image processing. Actin cytoskeleton images were processed as described in the Materials and methods. The processed images for a X-bow-shaped cell are shown. (A) Original immunofluorescence image in greyscale. (B) Preprocessing: contrast-limited adaptive histogram equalization. (C) Correlation image result from detection with [fiberscore]{.smallcaps}. (D) Orientation image result from detection with [fiberscore]{.smallcaps}. (E) Postprocessing: threshold. (F) Postprocessing: skeleton.](febs-280-4474-f2){#fig02}

We first statistically analyzed the actin fibre orientations using images similar to those shown in [Fig. 2](#fig02){ref-type="fig"}D to quantitatively illustrate that HCAECs conforming to one micropatterned shape are indeed unique in cytoskeletal organization compared to those of another micropatterned shape. Immunofluorescent actin images from each shape were tiled into grid regions and the two-sample Kolmogorov--Smirnov (KS) test [@b30] was utilized to determine whether fibre orientation between cell shapes is truly unique and reproducible in structure ([Table 1](#tbl1){ref-type="table"}). High scores (closer to 1.0) occur when actin fibre orientations are largely dissimilar between cells and were observed across shape to shape comparisons. With the exception of normal-shaped cells (which demonstrated high actin orientation variability), we find relatively low rejection scores when comparing all the individual cells with their underlying cumulative tiling, meaning that cells of the same shape have fibre orientations more similar to each other than to other shapes. Note that these comparisons are not symmetric (e.g. comparing X-bow to disk yields slightly different scores than disk to X-bow). This asymmetry is a result of the fact that the orientation of individual images is being compared to the cumulative histogram of a specific shape; we are thus comparing individual disk image fibre orientations with the cumulative X-bow orientations and *vice versa*. These comparisons will yield similar but not identical results. These findings strongly validate the idea that the cellular morphologies induced by the micropatterned substrates result in reproducibly unique actin orientations between cell shapes. The analysis of shapes using the tiled grid regions, however, shows similarities in certain regions of a cell between shapes. Detailed analysis of the dominant and second dominant angles in actin orientation between cell shapes revealed that (a) crossbow-shaped cells have more contribution from actin angles close to 0^°^ along the horizontal projection and angles oriented in opposite directions when comparing the widest regions of the crossbow with the narrowest regions; (b) disk-shaped cells have a more uniform distribution of actin angle orientations; (c) H-shaped cells have more contributions from angles close to 0^°^ along the vertical centre; and (d) Y- and L-shaped cells display non-uniform orientation distributions each with a different dominant angle ([Fig. 3](#fig03){ref-type="fig"}A--C). This 3 × 3 tiling is applied in the same manner to all images; the consistency in the KS test results indicate the robustness of the results with respect to this choice of tiling. Note that in regions where it appears that there are no fibres and thus no orientation information (e.g. Y-shape left upper and lower corners) as a result of image variation, we do obtain a small amount of orientation information, as shown in [Fig. 3](#fig03){ref-type="fig"}C. We then analyzed the median fibre length using images similar to [Fig. 3](#fig03){ref-type="fig"}C between normal and micropatterned HCAECs using the previously described modified [fiberscore]{.smallcaps} analysis. As indicated in [Fig. 3](#fig03){ref-type="fig"}D, the median fibre length (± SEM) for normal-shaped HCAECs was significantly greater (6.84 ± 0.9 μm) than for crossbow- (2.9 ± 0.1 μm), disk- (3.3 ± 0.2 μm), H- (2.6 ± 0.2 μm), Y- (2.9 ± 0.3 μm) and L- (4.3 ± 0.4 μm) shaped cells. Thus, these data strongly indicate that actin orientation and length are truly unique between each cell shape and, if genomic alterations are truly shape and actin confirmation dependent, this model system is sufficient in both design and reproducibility to identify those changes.

###### 

Correlation of actin fibre orientation between each shape. The data presented are the mean scores of the output via a two-sample KS test (scale of 0 to 1 where 1 completely rejects the null hypothesis of the test)

                Crossbow   Disk   H-cell   Y-cell   L-cell   Normal cell
  ------------- ---------- ------ -------- -------- -------- -------------
  Crossbow      0.54       0.93   0.94     0.68     0.96     0.95
  Disk          0.96       0.78   0.95     0.99     0.91     0.99
  H-cell        0.93       0.91   0.6      0.93     0.75     0.95
  Y-cell        0.71       0.99   0.94     0.5      0.95     0.96
  L-cell        0.99       0.95   0.88     0.97     0.39     0.93
  Normal cell   0.95       1      0.89     0.95     0.88     0.86

![Quantification of actin fibre orientation and length in normal and micropatterned HCAECs. (A) [fiberscore]{.smallcaps}: orientation heatmaps depicting actin orientation for normal and micropatterned HCAECs in relation to their cellular axis. An angle starting at 0° is coincident with the *x*-axis and increases in a counter clockwise direction to 180°. (B) Representative 3 × 3 tiling of a crossbow-shaped HCAEC orientation heatmap. (C) Dominant and second dominant fibre angles in each grid block for each shape. The dominant and second dominant angles are calculated by combining angle information in all images of the particular shape tile. Angles are detected using the restricted angle resolution of [fiberscore]{.smallcaps}. (D) [fiberscore]{.smallcaps}: correlation quantification of the median fibre length of the actin fibres from normal and micropatterned HCAECs. At least 11--14 images were analyzed from each condition.](febs-280-4474-f3){#fig03}

Using shape-engineered endothelial cells on circular, square and various rectangular adhesive micropatterns mimicking elongated bipolar shapes, Versaevel *et al*. [@b25] indicated that cell elongation and spreading is a key parameter of nuclear deformation and this process is absolutely dependent on lateral compressive forces generated by an actomyosin-mediated mechanism. It was further demonstrated that cell elongation leads to successive changes in the level of chromatin condensation as the nuclear shape index is decreased. To test whether changes in cell shape in general (as opposed to solely cell elongation, as shown previously) [@b25] induce nuclear deformation, we analyzed top and side images of the nuclei from normal and micropatterned HCAECs using confocal microscopy (at least 40 nuclei per condition). The prototypical HCAEC nucleus is ∼ 15--18 μm long by 5--8 μm high and maintains a distinctive oval appearance ([Fig. 4](#fig04){ref-type="fig"}A, left), whereas deformed nuclei show variability from this norm, as shown in [Fig. 4](#fig04){ref-type="fig"}A (middle and right). Although irregularity in nuclear shape occurred relatively infrequently in normal-shaped cells (∼ 6% of the cells exhibited nonprototypical nuclei), the percentages were significantly higher in the micropatterned HCAECs, ranging from just over 20% of the L- and Y shaped cells to approximately three-quarters of the population in disc shaped cells ([Fig. 4](#fig04){ref-type="fig"}B).

![Micropatterning of HCAECs increases the incidence of nuclear deformation. (A) Confocal top and side images of DAPI-stained HCAEC nuclei. The prototypical normal nucleus is shown in the left panel, whereas examples of deformed nuclei are shown in the middle and right panels. (B) Percentage of the cell population exhibiting a deformed nucleus. At least 40 nuclei were counted for each condition.](febs-280-4474-f4){#fig04}

Morphological restriction in HCAECs results in large-scale changes in endothelial global gene transcription independent of the unique shape adopted
---------------------------------------------------------------------------------------------------------------------------------------------------

Distinct micropattern-mediated alterations in cell shape have been shown to affect lineage specification in mesenchymal progenitor cells [@b14], although less is known regarding how changes in cell morphology affect terminally differentiated cell types (such as an endothelial cells). Thus, we sought to address two questions: (a) does morphological restriction affect endothelial global transcription and (b) does a distinct cellular morphology uniquely affect endothelial global transcription. Using the reproducible micropatterning system described above, we can effectively address both questions.

We performed whole genome microarray analysis on total RNA collected from nonrestricted and micropatterned HCAECs cultured on 96-well collagen I-coated micropatterned plates and grown in standard growth media. The nonrestricted cells were grown at low confluence to minimize cell-to-cell contacts. Our data revealed large-scale alterations in gene expression as a result of HCAEC morphological restriction. As shown in [Fig. 5](#fig05){ref-type="fig"}A,B and [Table 2](#tbl2){ref-type="table"} statistically relevant gene expression changes were equal or greater than two-fold in magnitude (*P* \< 0.05) in at least one of the cell shapes compared to normally-shaped HCAECs cells cultured on the same micropatterned plate. The complete data set is publically available via the Gene Expression Omnibus (<http://www.ncbi.nlm.nih.gov/geo>) (accession number GSE43349). These results provide strong evidence that restricting cell shape induces changes in the global transcriptional patterns of endothelial cells.

###### 

Two-fold or greater alterations in gene expression compared to normal-shaped coronary artery endothelial cells (standard growth media)

  Gene symbol       Gene name                                                                      Accession number   X-bow   Disc   H      L       Y
  ----------------- ------------------------------------------------------------------------------ ------------------ ------- ------ ------ ------- ------
  TMEM100           Transmembrane protein 100, TV2                                                 NM_018286.2        6.4     5      6.3    6.4     7
  PTGS2             Prostaglandin-endoperoxide synthase 2                                          NM_000963.1        4.3     3.7    4      3.9     4.1
  IRF6              Interferon regulatory factor 6                                                 NM_006147.2        3.4     2.9    2.8    3       3.5
  ALPL              Alkaline phosphatase, liver/bone/kidney, TV1                                   NM_000478.3        3.3     3.5    3.3    3.4     3.1
  C8orf4            Chromosome 8 ORF 4                                                             NM_020130.3        3.2     2.6    3.1    2.7     3
  HEY1              Hairy/enhancer-of-split related with YRPW motif 1, TV2                         NM_001040708.1     3.1     2.7    2.7    2.7     3.1
  BMF               Bcl2 modifying factor, TV2                                                     NM_033503.3        3       3.3    3      2.9     3
  BMF               Bcl2 modifying factor, TV4                                                     NM_001003943.1     3       3.1    2.9    2.7     2.9
  LOC730525         Hypothetical protein                                                           XM_001126202.1     3       2.8    2.7    3       4
  SEMA3G            Semaphorin 3G                                                                  NM_020163.1        2.9     3.2    2.6    2.9     2.6
  HSD17B11          Hydroxysteroid (17β) dehydrogenase 11                                          NM_016245.2        2.9     2.2    2.6    2.5     3.3
  F2RL3             Coagulation factor II (thrombin) receptor-like 3                               NM_003950.2        2.8     2.8    2.7    2.9     2.6
  TOX2              TOX high mobility group box family member 2, TV4                               NM_001098796.1     2.8     3.1    2.7    2.4     2.6
  C20orf100         TOX high mobility group box family member 2                                    NM_032883.1        2.8     2.6    2.4    2.3     3.1
  TOX2              TOX high mobility group box family member 2, TV1                               NM_001098797.1     2.8     2.8    2.6    2.3     2.9
  SPRY1             Sprouty homologue 1, antagonist of FGF signalling (*Drosophila*), TV1          NM_005841.1        2.7     2.5    2.7    2.6     3.3
  SPRY1             Sprouty homologue 1, antagonist of FGF signalling (*Drosophila*), TV2          NM_199327.1        2.7     2.4    2.7    2.7     3.1
  ZBTB16            Zinc finger and BTB domain containing 16, TV2                                  NM_001018011.1     2.6     2.6    2.6    2.7     2.7
  TMEM140           Transmembrane protein 140                                                      NM_018295.2        2.6     2.2    2.3    2       2.5
  NPTX1             Neuronal pentraxin I                                                           NM_002522.2        2.6     2.7    2.2    2.1     2.6
  SMAD7             SMAD family member 7                                                           NM_005904.2        2.6     2.4    2.5    2.7     2.6
  ANKRD1            Ankyrin repeat domain 1 (cardiac muscle)                                       NM_014391.2        2.5     2.8    2.7    2.7     3.1
  CXCR4             Chemokine (C-X-C motif) receptor 4, TV1                                        NM_001008540.1     2.4     2.5    2.3    2.1     2.5
  SYNM              Synemin, intermediate filament protein, TVB                                    NM_015286.5        2.4     2.1    2      2.2     2.4
  HLX               H2.0-like homeobox                                                             NM_021958.2        2.4     2.7    2.2    2       2
  EFNB2             Ephrin-B2                                                                      NM_004093.2        2.3     2.2    2.1    2       2.2
  TNFAIP8L3         Tumour necrosis factor, α-induced protein 8-like 3                             NM_207381.2        2.2     2.3    1.9    2       2.2
  NEDD9             Neural precursor cell expressed, develop. down-regulated 9 , TV2               NM_182966.2        2.2     1.7    1.9    1.9     2.6
  GDF15             Growth differentiation factor 15                                               NM_004864.1        2.1     2.2    2      1.9     2.1
  CALCRL            Calcitonin receptor-like                                                       NM_005795.4        2.1     1.8    2      1.7     2
  RDX               Radixin, TV3                                                                   NM_002906.3        2.1     1.9    1.9    1.6     2.1
  MMP10             Matrix metallopeptidase 10 (stromelysin 2)                                     NM_002425.1        2       2      1.6    1.4     1.7
  CMTM8             CKLF-like MARVEL transmembrane domain containing 8                             NM_178868.3        2       2      1.8    1.8     2
  C13orf15          Regulator of cell cycle                                                        NM_014059.2        2       2      1.8    1.7     2.1
  NDRG4             NDRG family member 4                                                           NM_022910.1        2       2.1    1.9    1.7     1.9
  LOC100132564      Hypothetical protein                                                           XM_001713808.1     2       2.3    1.4    1.4     2.1
  CRYAB             Crystallin, alpha B                                                            NM_001885.1        1.9     1.9    1.7    1.9     2.5
  RRAGD             Ras-related GTP binding D                                                      NM_021244.3        1.9     1.6    1.8    1.7     2
  IL10              Interleukin 10                                                                 NM_000572.2        1.9     1.6    1.4    1.5     2.6
  LOC100129211      Hypothetical protein                                                           XM_001718981.1     1.8     1.8    1.5    1.6     2
  GRAP              GRB2-related adaptor protein                                                   NM_006613.3        1.8     1.8    1.6    1.6     2
  C8orf45           Chromosome 8 open reading frame 45                                             NM_173518.2        1.8     1.7    1.5    1.6     2.1
  PDGFB             Platelet-derived growth factor beta (oncogene homolog), TV1                    NM_002608.1        1.8     2.2    2      1.8     2
  LOC100190986      Nuclear pore complex interacting protein pseudogene                            NR_024456.1        1.8     1.7    1.8    1.6     2.5
  PGF               Placental growth factor                                                        NM_002632.4        1.8     2      1.6    1.5     1.6
  LOC100132247      Nuclear pore complex interacting protein related gene                          NM_001135865.1     1.7     1.4    2.2    1.7     1.9
  FAM175A           Family with sequence similarity 175, member A                                  NM_139076.2        1.7     1.4    1.4    1.4     2.1
  PDGFB             Platelet-derived growth factor beta (oncogene homolog), TV2                    NM_033016.1        1.7     2.1    2.1    1.7     1.7
  LOC440353         Nuclear pore complex interacting protein pseudogene                            NR_002603.1        1.7     1.5    2.1    1.7     2.1
  KIAA1751          KIAA1751                                                                       NM_001080484.1     1.6     1.7    1.5    1.5     2.5
  LOC613037         Nuclear pore complex interacting protein pseudogene                            NR_002555.2        1.6     1.4    2      1.5     2.1
  MAGT1             Magnesium transporter 1                                                        NM_032121.4        1.6     1.7    1.7    1.5     2
  ZNF738            Misc_RNA, partial miscRNA                                                      XR_040185.1        1.6     1.5    1.4    1.4     2
  DMC1              DMC1 dosage suppressor of mck1 homolog                                         NM_007068.2        1.6     1.7    1.4    1.4     2.4
  LOC729978         Similar to LOC339047 protein, TV2                                              XM_001723016.1     1.6     1.5    1.5    1.3     2
  LOC23117          KIAA0220-like protein, TV16                                                    XM_933834.2        1.6     1.5    1.6    1.6     2.1
  LOC100132585      Hypothetical protein                                                           XM_001722111.1     1.6     1.5    1.5    1.3     2.2
  LOC440348         Nuclear pore complex interacting protein-like 2                                NM_001018059.2     1.6     1.7    1.9    1.7     2.1
  LOC440345         Hypothetical protein, TV6                                                      XM_933717.1        1.6     1.5    2.1    1.7     2.5
  LOC728809         Hypothetical LOC728809                                                         XM_001719546.1     1.6     1.4    1.4    1.3     2
  TRIM13            Tripartite motif containing 13, TV4                                            NM_001007278.1     1.6     1.5    1.6    1.5     2.1
  IMAGE:2760091 3   NCI_CGAP_Lu28 Homo sapiens cDNA clone IMAGE:2760091 3                          AW276479           1.6     1.4    1.6    1.5     2.5
  CATSPER2          Cation channel, sperm associated 2, TV4                                        NM_172097.1        1.5     1.3    1.4    1.4     2.1
  MCART1            Mitochondrial carrier triple repeat 1                                          NM_033412.1        1.5     1.7    1.3    1.2     2.3
  NLRP8             NLR family, pyrin domain containing 8                                          NM_176811.2        1.5     1.5    1.3    1.4     2.1
  LOC255167         Uncharacterized LOC255167                                                      NR_024424.1        1.5     1.6    1.3    1.3     2.2
  DDX51             DEAD (Asp-Glu-Ala-Asp) box polypeptide 51                                      NM_175066.2        1.4     1.3    1.3    1.4     2
  C21orf55          Chromosome 21 ORF 55                                                           NM_017833.2        1.4     1.4    1.2    1.3     2.1
  LOC90586          Amine oxidase, copper containing 3 pseudogene                                  NR_002773.1        1.4     1.6    1.4    1.5     2.2
  LOC100130168      Hypothetical protein                                                           XM_001719127.1     1.4     1.4    1.2    1.2     2
  MAPK8IP3          Mitogen-activated protein kinase 8 interacting protein 3, TV2                  NM_001040439.1     1.4     2      1.6    1.6     1.7
  ZNF682            Zinc finger protein 682, TV1                                                   NM_033196.2        1.4     1.4    1.3    1.3     2.2
  ZNF486            Zinc finger protein 486                                                        XM_371152.3        1.3     1.4    1      1.2     2.1
  SULT1A1           Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1, TV3       NM_177530.1        1.3     1.4    1.4    1.3     2
  LOC100128510      Hypothetical protein                                                           XM_001715759.1     1.3     1.5    1.4    1.5     2
  LOC653994         Similar to eukaryotic translation initiation factor 4H, TV2                    XM_944429.1        −1.3    −2.2   −1.3   −1.5    1
  LOC648024         Similar to eukaryotic translation initiation factor 4A, TV1                    XR_018316.1        −1.3    −1.8   −1.6   −2.1    −1.3
  NDUFA8            NADH dehydrogenase (ubiquinone) 1α subcomplex, 8                               NM_014222.2        −1.4    −1.3   −1.7   −2.0    −1.4
  TNPO1             Transportin 1, TV2                                                             NM_153188.2        −1.4    −2.3   −1.5   −1.7    −1.3
  SNAP23            Synaptosomal-associated protein, 23 kDa, TV1                                   NM_003825.2        −1.4    −2.0   −1.4   −1.6    −1.3
  TCEA1             Transcription elongation factor A (SII), TV2                                   NM_201437.1        −1.4    −2.0   −1.6   −1.8    −1.4
  ALCAM             Activated leukocyte cell adhesion molecule                                     NM_001627.2        −1.4    −1.4   −1.6   −2.0    −1.8
  TCEAL8            Transcription elongation factor A (SII)-like 8, TV2                            NM_001006684.1     −1.4    −1.5   −1.7   −2.0    −1.4
  TMEM189-UBE2V1    TMEM189-UBE2V1 readthrough transcript, TV2                                     NM_003349.4        −1.4    −2.0   −1.5   −1.7    −1.3
  LOC730052         Misc_RNA (LOC730052)                                                           XR_016054.2        −1.4    −2.0   −1.4   −1.7    −1.3
  TXNDC5            Thioredoxin domain containing 5 (endoplasmic reticulum), TV1                   NM_030810.2        −1.4    −2.0   −1.4   −1.5    −1.6
  BCL2L1            BCL2-like 1, nuclear gene encoding mitochondrial protein, TV1                  NM_138578.1        −1.5    −2.0   −1.3   −1.6    −1.3
  EIF4G2            Eukaryotic translation initiation factor 4γ, 2, TV1                            NM_001418.3        −1.5    −2.2   −1.5   −2.0    −1.5
  TCP1              T-complex 1, TV1                                                               NM_030752.2        −1.5    −2.1   −1.4   −1.8    −1.4
  CCT6A             Chaperonin containing TCP1, subunit 6A (zeta 1), TV1                           NM_001762.3        −1.5    −2.1   −1.5   −1.9    −1.4
  LOC644063         Similar to heterogeneous nuclear ribonucleoprotein K                           XR_016547.1        −1.5    −2.2   −1.6   −2.0    −1.3
  LSM5              LSM5 homologue, U6 small nuclear RNA associated (*Saccharomyces cerevisiae*)   NM_012322.1        −1.5    −1.6   −2.0   −1.9    −1.8
  FEZ2              Fasciculation and elongation protein zeta 2 (zygin II), TV1                    NM_005102.2        −1.5    −1.7   −1.8   −2.1    −1.6
  C14orf149         Chromosome 14 ORF 149                                                          NM_144581.1        −1.5    −1.6   −1.8   −2.0    −1.9
  LOC728059         Misc_RNA                                                                       XR_015606.1        −1.5    −2.4   −1.6   −2.3    −1.7
  THOC4             THO complex 4                                                                  XM_001134346.1     −1.5    −1.8   −1.6   −2.0    −1.5
  LYPLA1            Lysophospholipase I                                                            NM_006330.2        −1.5    −1.9   −1.8   −2.1    −1.5
  EDG1              Endothelial differentiation, sphingolipid G-protein-coupled receptor, 1        NM_001400.3        −1.5    −1.5   −1.5   −2.2    −1.6
  LOC648695         Similar to retinoblastoma binding protein 4, TV5                               XM_944246.2        −1.5    −2.2   −1.8   −2.2    −1.7
  MALL              Mal, T-cell differentiation protein-like                                       NM_005434.3        −1.5    −1.3   −1.7   −2.0    −1.7
  ZFAND6            Zinc finger, AN1-type domain 6                                                 NM_019006.2        −1.5    −2.2   −1.6   −1.8    −1.6
  ADK               Adenosine kinase, transcript variant ADK-short                                 NM_001123.2        −1.5    −1.6   −1.9   −2.0    −1.5
  ZYX               Zyxin, TV1                                                                     NM_003461.4        −1.5    −1.4   −2.0   −1.7    −1.7
  PAPSS2            3′-phosphoadenosine 5′-phosphosulfate synthase 2, TV1                          NM_004670.3        −1.5    −1.5   −1.7   −2.1    −1.5
  G3BP2             GTPase activating protein (SH3 domain) binding protein 2, TV3                  NM_203504.1        −1.5    −1.6   −1.6   −2.1    −1.6
  LOC100130561      Similar to high-mobility group protein 1-like 10, TV2                          XM_001723189.1     −1.5    −2.1   −1.6   −1.9    −1.5
  HIGD1A            HIG1 hypoxia inducible domain family, member 1A, TV1                           NM_001099668.1     −1.6    −2.0   −1.8   −2.1    −1.7
  EPB41L3           Erythrocyte membrane protein band 4.1-like 3                                   NM_012307.2        −1.6    −1.7   −1.6   −2.0    −1.8
  IARS              Isoleucyl-tRNA synthetase, TV short                                            NM_002161.3        −1.6    −1.5   −1.7   −2.0    −1.5
  RRAS2             Related RAS viral (r-ras) oncogene homologue 2                                 NM_012250.3        −1.6    −1.9   −1.8   −2.0    −1.3
  RANBP1            RAN binding protein 1                                                          NM_002882.2        −1.6    −1.6   −2.1   −2.0    −1.7
  NOL6              Nucleolar protein family 6 (RNA-associated), TV γ                              NM_139235.3        −1.6    −1.3   −2.0   −1.7    −1.5
  C18orf55          Chromosome 18 ORF 55                                                           NM_014177.1        −1.6    −1.7   −1.7   −2.1    −1.6
  CSE1L             CSE1 chromosome segregation 1-like (yeast)                                     NM_001316.2        −1.6    −1.6   −1.8   −2.0    −1.6
  TIMM23            Translocase of inner mitochondrial membrane 23 homologue                       NM_006327.2        −1.6    −1.7   −1.8   −2.1    −1.6
  FHL2              Four and a half LIM domains 2, TV4                                             NM_201557.2        −1.6    −1.6   −1.8   −2.0    −1.6
  AP1S1             Adaptor-related protein complex 1, sigma 1 subunit, TV4                        NM_057089.2        −1.6    −1.5   −1.9   −2.1    −1.4
  HNRPA2B1          Heterogeneous nuclear ribonucleoprotein A2/B1, TV B1                           NM_031243.1        −1.6    −1.5   −1.8   −2.0    −1.8
  CCNC              Cyclin C, TV2                                                                  NM_001013399.1     −1.6    −2.0   −1.7   −1.9    −1.5
  PTPLAD1           Protein tyrosine phosphatase-like A domain containing 1                        NM_016395.2        −1.6    −1.7   −1.8   −2.1    −1.5
  HNRNPK            Heterogeneous nuclear ribonucleoprotein K, TV2                                 NM_031263.2        −1.6    −1.8   −1.5   −2.0    −1.5
  HAT1              Histone acetyltransferase 1, TV1                                               NM_003642.2        −1.6    −1.7   −2.0   −1.9    −1.7
  PSME3             Proteasome (prosome, macropain) activator subunit 3, TV1                       NM_005789.2        −1.6    −1.3   −2.0   −2.0    −1.6
  HIGD1A            HIG1 hypoxia inducible domain family, member 1A, TV1                           NM_001099668.1     −1.6    −1.7   −1.8   −2.1    −1.6
  ARMCX3            Armadillo repeat containing, X-linked 3, TV2                                   NM_177947.2        −1.6    −2.0   −1.5   −2.0    −1.6
  LOC100128266      PREDICTED: Misc_RNA                                                            XR_038984.1        −1.6    −2.1   −1.8   −2.1    −1.7
  DCBLD2            Discoidin, CUB and LCCL domain containing 2                                    NM_080927.3        −1.6    −1.6   −2.1   −1.9    −1.8
  SMS               Spermine synthase                                                              NM_004595.2        −1.6    −1.9   −1.8   −2.0    −1.7
  TPM3              Tropomyosin 3, TV1                                                             NM_152263.2        −1.6    −1.9   −1.8   −2.1    −1.4
  LOC653884         Similar to FUS interacting protein (serine-arginine rich) 1                    XM_936240.1        −1.6    −1.9   −1.6   −2.0    −1.5
  ATP5G1            ATP synthase, mitochondrial Fo complex, subunit C1, TV2                        NM_001002027.1     −1.6    −1.5   −1.9   −2.0    −1.7
  SDCBP             Syndecan binding protein (syntenin), TV2                                       NM_001007067.1     −1.6    −2.0   −1.6   −2.1    −1.7
  MCM6              Minichromosome maintenance complex component 6                                 NM_005915.4        −1.6    −1.7   −2.0   −2.0    −1.7
  BRIX1             BRX1, biogenesis of ribosomes, homologue (*S. cerevisiae*)                     NM_018321.3        −1.6    −1.7   −1.7   −2.0    −1.7
  RPL29             Ribosomal protein L29                                                          NM_000992.2        −1.6    −2.1   −2.0   −2.2    −1.6
  LOC644330         Similar to tropomyosin 3 isoform 2                                             XR_017492.1        −1.6    −2.0   −1.8   −1.9    −1.6
  LPXN              Leupaxin                                                                       NM_004811.1        −1.6    −1.6   −1.9   −2.0    −1.8
  LOC100130506      Hypothetical protein                                                           XM_001724500.1     −1.6    −1.7   −2.0   −2.0    −1.7
  DDX21             DEAD (Asp-Glu-Ala-Asp) box polypeptide 21                                      NM_004728.2        −1.6    −1.6   −1.7   −2.0    −1.5
  LDHA              Lactate dehydrogenase A                                                        NM_005566.1        −1.6    −1.6   −1.9   −2.0    −1.8
  LOC642590         Misc_RNA                                                                       XR_016251.2        −1.6    −1.7   −2.0   −1.9    −1.7
  FKBP14            FK506 binding protein 14, 22 kDa                                               NM_017946.2        −1.6    −1.7   −1.9   −2.1    −1.6
  NME1              NME/NM23 nucleoside diphosphate kinase 1, TV2                                  NM_000269.2        −1.6    −1.8   −2.1   −2.1    −1.7
  AHNAK             AHNAK nucleoprotein, TV1                                                       NM_001620.1        −1.6    −1.6   −2.0   −1.8    −1.4
  CKS2              CDC28 protein kinase regulatory subunit 2                                      NM_001827.1        −1.6    −1.5   −2.0   −2.1    −1.7
  CYCSL1            Cytochrome c, somatic-like 1 on chromosome 6                                   NR_001561.1        −1.6    −2.0   −1.9   −2.1    −1.7
  LOC646347         Misc_RNA                                                                       XR_017680.1        −1.7    −1.9   −1.9   −2.1    −1.8
  WDR4              WD repeat domain 4, TV2                                                        NM_033661.3        −1.7    −1.5   −1.9   −2.2    −1.6
  ALDH1A3           Aldehyde dehydrogenase 1 family, member A3                                     NM_000693.1        −1.7    −1.7   −2.0   −2.4    −1.9
  CLINT1            Clathrin interactor 1                                                          NM_014666.2        −1.7    −1.6   −1.8   −2.0    −1.6
  GNG12             Guanine nucleotide binding protein (G protein), γ 12                           NM_018841.4        −1.7    −2.5   −1.6   −2.1    −1.6
  TOMM5             Translocase of outer mitochondrial membrane 5 homologue, TV1                   NM_001001790.2     −1.7    −1.7   −2.0   −1.9    −1.9
  MPZL2             Myelin protein zero-like 2, TV1                                                NM_005797.2        −1.7    −1.8   −1.9   −2.2    −1.7
  DUSP14            Dual specificity phosphatase 14                                                NM_007026.2        −1.7    −1.6   −1.9   −2.1    −1.9
  IDH1              Isocitrate dehydrogenase 1 (NADP^+^), soluble                                  NM_005896.2        −1.7    −2.0   −1.7   −1.9    −1.8
  CYTL1             Cytokine-like 1                                                                NM_018659.2        −1.7    −1.8   −2.0   −2.1    −1.6
  MLKL              Mixed lineage kinase domain-like                                               NM_152649.1        −1.7    −1.6   −1.8   −2.0    −1.6
  CTHRC1            Collagen triple helix repeat containing 1                                      NM_138455.2        −1.7    −1.8   −1.8   −2.0    −1.6
  C6orf173          Chromosome 6 ORF 173                                                           NM_001012507.1     −1.7    −1.6   −2.1   −1.8    −1.8
  MGC40489          Hypothetical protein                                                           XR_016048.1        −1.7    −1.8   −1.7   −2.0    −1.7
  KDELR3            KDEL endoplasmic reticulum protein retention receptor 3, TV1                   NM_006855.2        −1.7    −1.6   −1.8   −1.8    −2.0
  TNFSF4            Tumour necrosis factor (ligand) superfamily, member 4                          NM_003326.2        −1.7    −1.7   −1.7   −2.1    −1.9
  AURKA             Aurora kinase A, TV5                                                           NM_198436.1        −1.7    −1.7   −2.1   −1.9    −1.9
  SMS               Spermine synthase                                                              NM_004595.2        −1.7    −2.0   −1.8   −2.0    −1.7
  RND3              Rho family GTPase 3                                                            NM_005168.3        −1.7    −1.6   −2.0   −1.9    −1.7
  CLDN5             Claudin 5 (transmembrane protein deleted in velocardiofacial syndrome)         NM_003277.2        −1.7    −1.4   −1.8   −2.1    −1.9
  EDN1              Endothelin 1                                                                   NM_001955.2        −1.7    −1.7   −2.0   −1.7    −1.7
  PVRL3             Poliovirus receptor-related 3                                                  NM_015480.1        −1.7    −1.6   −2.0   −2.1    −1.8
  LOX               Lysyl oxidase                                                                  NM_002317.3        −1.7    −1.9   −1.9   −2.0    −1.6
  ICMT              Isoprenylcysteine carboxyl methyltransferase                                   NM_012405.3        −1.7    −1.6   −2.0   −1.8    −1.7
  PRDX3             Peroxiredoxin 3, nuclear gene encoding mitochondrial protein, TV1              NM_006793.2        −1.7    −1.9   −1.8   −2.1    −1.6
  TUBB6             Tubulin, β6 class V                                                            NM_032525.1        −1.7    −2.2   −1.6   −1.8    −1.6
  VAMP5             Vesicle-associated membrane protein 5 (myobrevin)                              NM_006634.2        −1.7    −1.9   −1.9   −2.1    −1.6
  MORF4L2           Mortality factor 4-like 2                                                      NM_012286.1        −1.7    −1.8   −1.9   −2.2    −1.7
  NOP56             NOP56 ribonucleoprotein homologue (yeast), TV1                                 NM_006392.2        −1.7    −1.8   −1.9   −2.1    −1.7
  HNRPK             Heterogeneous nuclear ribonucleoprotein K, TV3                                 NM_031263.1        −1.7    −1.8   −1.8   −2.0    −1.9
  RNF121            Ring finger protein 121, TV1                                                   NM_018320.3        −1.7    −1.4   −2.0   −2.0    −1.8
  KDELC2            KDEL (Lys-Asp-Glu-Leu) containing 2                                            NM_153705.4        −1.7    −1.7   −1.9   −2.2    −1.8
  FJX1              Four jointed box 1 (*Drosophila*)                                              NM_014344.2        −1.7    −1.6   −2.0   −2.1    −1.9
  DNMT1             DNA (cytosine-5-)-methyltransferase 1                                          NM_001379.1        −1.7    −1.4   −1.8   −2.0    −1.7
  LOC729779         Misc_RNA (LOC729779)                                                           XR_019592.2        −1.7    −2.0   −1.8   −1.6    −1.7
  FABP5             Fatty acid binding protein 5 (psoriasis-associated)                            NM_001444.1        −1.7    −1.6   −1.9   −2.0    −1.7
  ZDHHC6            Zinc finger, DHHC-type containing 6                                            NM_022494.1        −1.7    −1.8   −1.9   −2.2    −1.7
  IL1RL1            Interleukin 1 receptor-like 1 (IL1RL1), TV2                                    NM_003856.2        −1.7    −1.9   −1.8   −2.0    −1.7
  EBNA1BP2          EBNA1 binding protein 2                                                        NM_006824.1        −1.7    −1.8   −2.1   −2.1    −1.6
  TFDP1             Transcription factor Dp-1                                                      NM_007111.3        −1.7    −1.6   −1.8   −2.1    −1.7
  PAICS             Phosphoribosylaminoimidazole succinocarboxamide synthetase, TV2                NM_006452.3        −1.7    −1.7   −2.0   −2.2    −1.6
  CISD1             CDGSH iron sulfur domain 1                                                     NM_018464.2        −1.7    −1.7   −2.2   −2.1    −1.7
  LOC100129086      Similar to HIG1 domain family, member 1A                                       XM_001725669.1     −1.7    −2.1   −2.0   −2.1    −1.7
  POLE4             Polymerase (DNA-directed), ε4, accessory subunit                               NM_019896.2        −1.8    −1.8   −2.0   −2.0    −1.6
  FER1L3            Fer-1-like 3, myoferlin (*Caenorhabditis elegans*), TV2                        NM_133337.1        −1.8    −1.5   −1.9   −2.0    −1.9
  PVRL3             Poliovirus receptor-related 3                                                  NM_015480.1        −1.8    −1.9   −2.2   −2.2    −1.9
  RANBP1            RAN binding protein 1                                                          NM_002882.2        −1.8    −2.1   −2.2   −2.3    −1.8
  RAB11A            RAB11A, member RAS oncogene family                                             NM_004663.3        −1.8    −1.5   −1.8   −2.0    −1.7
  SLC38A1           Solute carrier family 38, member 1, TV1                                        NM_030674.3        −1.8    −1.7   −2.1   −2.0    −2.0
  IL8               Interleukin 8                                                                  NM_000584.2        −1.8    −1.9   −2.1   −2.0    −1.7
  LOC100132715      Misc_RNA                                                                       XR_039129.1        −1.8    −1.5   −1.9   −2.0    −1.6
  LOC644330         Similar to tropomyosin 3 isoform 2                                             XR_017492.1        −1.8    −2.4   −2.0   −2.1    −1.7
  ZNF185            Zinc finger protein 185 (LIM domain)                                           NM_007150.2        −1.8    −1.6   −1.9   −2.0    −1.7
  COL13A1           Collagen, type XIII, α1, TV19                                                  NM_080815.2        −1.8    −1.6   −2.1   −2.0    −1.8
  PKD2              Polycystic kidney disease 2 (autosomal dominant)                               NM_000297.2        −1.8    −1.6   −1.9   −2.0    −2.0
  MAGED1            Melanoma antigen family D, 1, TV2                                              NM_006986.3        −1.8    −1.7   −1.9   −1.9    −2.3
  POLE3             Polymerase (DNA directed), ε3 (p17 subunit)                                    NM_017443.3        −1.8    −1.6   −2.0   −2.1    −1.7
  CORO1C            Coronin, actin binding protein, 1C, TV1                                        NM_014325.2        −1.8    −1.5   −1.8   −2.0    −1.8
  LOC652481         Similar to mitochondrial import inner membrane translocase subunit Tim23       XM_941942.1        −1.8    −2.2   −1.9   −1.9    −1.7
  SLFN11            Schlafen family member 11                                                      NM_152270.2        −1.8    −1.4   −2.0   −1.9    −1.8
  PRNP              Prion protein (PRNP), TV3                                                      NM_001080121.1     −1.8    −1.7   −1.9   −2.0    −2.2
  FRMD6             FERM domain containing 6                                                       NM_152330.2        −1.8    −1.8   −2.1   −2.2    −1.9
  PTS               6-pyruvoyltetrahydropterin synthase                                            NM_000317.1        −1.8    −1.8   −1.9   −2.0    −1.5
  PECI              Enoyl-CoA δ isomerase 2 (ECI2), TV1                                            NM_006117.2        −1.8    −2.4   −2.2   −2.5    −1.9
  MGAT2             Mannosyl-glycoprotein-acetylglucosaminyltransferase, TV2                       NM_001015883.1     −1.8    −2.1   −1.6   −2.1    −1.6
  ATP6V0E2          ATPase, H^+^ transporting V0 subunit e2, TV1                                   NM_145230.2        −1.8    −1.5   −2.0   −1.9    −1.8
  RPL6              Ribosomal protein L6, TV1                                                      NM_001024662.1     −1.8    −2.0   −1.9   −2.2    −1.8
  CGNL1             Cingulin-like 1                                                                NM_032866.3        −1.8    −1.8   −2.2   −2.3    −2.0
  LDHA              Lactate dehydrogenase A, TV2                                                   NM_001135239.1     −1.8    −1.8   −2.0   −2.1    −1.9
  PGK1              Phosphoglycerate kinase 1                                                      NM_000291.2        −1.8    −1.9   −1.9   −2.2    −1.8
  CCND3             Cyclin D3                                                                      NM_001760.2        −1.8    −1.6   −2.0   −2.0    −2.0
  SFRS2             Serine/arginine-rich splicing factor 2                                         NM_003016.3        −1.8    −1.7   −2.3   −2.2    −1.9
  F2RL1             Coagulation factor II (thrombin) receptor-like 1                               NM_005242.3        −1.8    −1.8   −1.8   −2.2    −1.8
  PLSCR4            Phospholipid scramblase 4                                                      NM_020353.1        −1.8    −1.7   −1.8   −2.1    −1.6
  KDELR3            KDEL endoplasmic reticulum protein retention receptor 3, TV2                   NM_016657.1        −1.8    −2.0   −2.0   −2.2    −1.9
  LOC653226         Similar to signal recognition particle 9 kDa protein (SRP9)                    XM_927451.2        −1.8    −2.2   −1.8   −2.0    −1.5
  LOC387882         Hypothetical protein                                                           NM_207376.1        −1.8    −1.8   −2.1   −2.1    −1.7
  PPM1F             Protein phosphatase, Mg^2+^/Mn^2+^ dependent, 1F                               NM_014634.2        −1.8    −1.4   −1.9   −2.1    −1.7
  PRICKLE1          Prickle homologue 1 (*Drosophila*)                                             NM_153026.1        −1.8    −1.4   −2.0   −1.7    −1.8
  TSPAN5            Tetraspanin 5                                                                  NM_005723.2        −1.8    −1.7   −2.0   −2.2    −1.6
  PDCD6IP           Programmed cell death 6 interacting protein                                    NM_013374.3        −1.8    −1.7   −1.8   −2.2    −1.9
  EFEMP1            EGF-containing fibulin-like extracellular matrix protein 1                     NM_004105.3        −1.8    −3.0   −1.8   −2.2    −1.7
  CDC20             Cell division cycle 20 homologue (*S. cerevisiae*)                             NM_001255.2        −1.8    −1.9   −2.1   −1.8    −2.0
  LOC642590         Misc_RNA                                                                       XR_037021.1        −1.8    −1.8   −1.8   −2.2    −1.7
  PRKAG2            Protein kinase, AMP-activated, γ2 noncatalytic subunit, TVb                    NM_024429.1        −1.9    −1.9   −2.0   −2.1    −2.0
  MRPL39            Mitochondrial ribosomal protein L39, TV1                                       NM_017446.3        −1.9    −1.9   −1.9   −2.2    −1.7
  TRAM2             Translocation associated membrane protein 2                                    NM_012288.3        −1.9    −1.5   −2.0   −2.1    −1.8
  B4GALT5           UDP-Gal:βGlcNAc β 1,4- galactosyltransferase, polypeptide 5                    NM_004776.2        −1.9    −1.8   −2.2   −2.4    −2.3
  TUBA1A            Tubulin, α1a                                                                   NM_006009.2        −1.9    −2.0   −1.8   −2.3    −1.9
  KPNA2             Karyopherin α2 (RAG cohort 1, importin α 1)                                    NM_002266.2        −1.9    −2.3   −2.0   −2.2    −1.9
  FER1L3            Fer-1-like 3, myoferlin (*C. elegans*) (FER1L3), TV1                           NM_013451.2        −1.9    −1.9   −1.8   −2.0    −2.0
  NLGN1             Neuroligin 1                                                                   NM_014932.2        −1.9    −1.9   −2.3   −2.5    −2.0
  ALDH3A2           Aldehyde dehydrogenase 3 family, member A2, TV2                                NM_000382.2        −1.9    −1.9   −1.8   −2.1    −1.8
  LOC732007         Similar to phosphoglycerate mutase 1                                           XR_015684.1        −1.9    −1.9   −1.8   −2.2    −2.0
  C21orf63          Family with sequence similarity 176, member C                                  NM_058187.3        −1.9    −1.7   −2.2   −1.9    −1.7
  MSRB3             Methionine sulfoxide reductase B3, TV1                                         NM_198080.2        −1.9    −2.1   −1.7   −2.0    −1.7
  PLXNA2            Plexin A2                                                                      NM_025179.3        −1.9    −1.5   −2.1   −1.9    −1.9
  UCHL3             Ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase)              NM_006002.3        −1.9    −2.0   −2.3   −2.3    −2.0
  MT1G              Metallothionein 1G                                                             NM_005950.1        −1.9    −1.4   −2.0   −1.8    −1.8
  NEXN              Nexilin (F actin binding protein), TV1                                         NM_144573.3        −1.9    −2.2   −2.1   −2.1    −1.9
  CRIM1             Cysteine rich transmembrane BMP regulator 1 (chordin-like)                     NM_016441.1        −1.9    −2.5   −2.0   −2.4    −1.9
  LOC644774         Similar to phosphoglycerate kinase 1                                           XM_927868.1        −1.9    −2.3   −2.1   −2.4    −2.0
  UBE2T             Ubiquitin-conjugating enzyme E2T (putative)                                    NM_014176.2        −1.9    −1.9   −2.0   −2.0    −1.8
  LOC441019         Hypothetical LOC441019                                                         XM_498969.2        −1.9    −1.5   −2.1   −2.1    −2.1
  PGAM1             Phosphoglycerate mutase 1 (brain)                                              NM_002629.2        −1.9    −2.4   −1.8   −1.9    −1.6
  LPHN2             Latrophilin 2                                                                  NM_012302.2        −1.9    −1.6   −2.1   −2.3    −1.9
  EHD4              EH-domain containing 4                                                         NM_139265.2        −1.9    −1.6   −1.9   −2.0    −1.7
  MYOF              Myoferlin, TV1                                                                 NM_013451.3        −1.9    −1.8   −1.9   −2.2    −1.9
  PTTG1             Pituitary tumour-transforming 1                                                NM_004219.2        −1.9    −2.2   −2.1   −2.1    −1.8
  TUBA1C            Tubulin, α1c                                                                   NM_032704.2        −1.9    −2.0   −1.9   −2.2    −1.9
  ANXA2             Annexin A2, TV2                                                                NM_001002857.1     −1.9    −2.8   −2.2   −2.5    −1.8
  FILIP1L           Filamin A interacting protein 1-like, TV3                                      NM_001042459.1     −1.9    −1.8   −2.1   −1.9    −2.0
  TRIP6             Thyroid hormone receptor interactor 6                                          NM_003302.2        −1.9    −1.8   −2.1   −1.9    −1.9
  GIMAP7            GTPase, IMAP family member 7                                                   NM_153236.3        −1.9    −1.9   −2.1   −2.6    −2.0
  PECI              Enoyl-CoA δ isomerase 2, TV1                                                   NM_006117.2        −1.9    −1.9   −2.1   −2.1    −1.9
  TMEM14A           Transmembrane protein 14A                                                      NM_014051.3        −1.9    −2.1   −2.1   −2.3    −2.3
  CALD1             Caldesmon 1 (CALD1), TV5                                                       NM_033140.2        −2.0    −2.0   −2.3   −2.1    −2.0
  LOC402221         Similar to actin α1 skeletal muscle protein                                    XM_938988.1        −2.0    −2.0   −1.8   −2.2    −2.2
  CCND2             Cyclin D2                                                                      NM_001759.2        −2.0    −1.7   −1.9   −2.1    −2.1
  PRNP              Prion protein (PRNP), TV2                                                      NM_183079.2        −2.0    −2.0   −2.2   −2.2    −2.4
  FRMD6             FERM domain containing 6, TV2                                                  NM_152330.3        −2.0    −2.0   −2.0   −2.1    −1.9
  EFHD2             EF-hand domain family, member D2                                               NM_024329.4        −2.0    −1.7   −2.2   −2.2    −2.0
  AADACL1           Arylacetamide deacetylase-like 1                                               NM_020792.3        −2.0    −2.3   −2.2   −2.4    −2.2
  TGM2              Transglutaminase 2, TV1                                                        NM_004613.2        −2.0    −1.8   −2.3   −2.1    −1.9
  CAV2              Caveolin 2 (CAV2), TV1                                                         NM_001233.3        −2.0    −2.7   −2.3   −2.6    −2.0
  NNMT              Nicotinamide *N*-methyltransferase                                             NM_006169.2        −2.0    −2.1   −2.2   −2.2    −2.0
  UAP1              UDP-*N*-acteylglucosamine pyrophosphorylase 1                                  NM_003115.3        −2.0    −1.6   −2.2   −2.0    −1.9
  TJP2              Tight junction protein 2 (zona occludens 2), TV2                               NM_201629.1        −2.0    −1.8   −2.2   −2.0    −2.0
  AURKA             Aurora kinase A, TV3                                                           NM_198434.1        −2.0    −1.9   −2.2   −2.1    −2.1
  CSTF3             Cleavage stimulation factor, 3′ pre-RNA, subunit 3, 77 kDa, TV2                NM_001033505.1     −2.0    −2.2   −2.1   −2.3    −1.9
  PTPLA             Protein tyrosine phosphatase-like, member A                                    NM_014241.3        −2.0    −1.9   −2.1   −2.3    −2.0
  CAV1              Caveolin 1, caveolae protein, 22 kDa                                           NM_001753.3        −2.0    −2.0   −2.3   −2.3    −1.9
  EXT1              Exostosin 1                                                                    NM_000127.2        −2.0    −1.7   −2.0   −2.4    −2.2
  CCNA2             Cyclin A2                                                                      NM_001237.2        −2.0    −1.9   −2.1   −1.9    −1.9
  CD59              CD59 molecule, complement regulatory protein, TV2                              NM_000611.4        −2.0    −1.5   −2.0   −2.1    −2.1
  TUBB2C            Tubulin, β4B class IVb                                                         NM_006088.5        −2.0    −1.9   −2.2   −2.4    −2.4
  SFRS3             Splicing factor, arginine/serine-rich 3                                        NM_003017.3        −2.0    −2.0   −2.1   −2.2    −2.0
  RAN               RAN, member RAS oncogene family                                                NM_006325.2        −2.0    −2.2   −2.3   −2.4    −2.0
  ADAM9             ADAM metallopeptidase domain 9, TV1                                            NM_003816.2        −2.0    −2.8   −2.0   −2.3    −1.9
  LRP8              Low density lipoprotein receptor-related protein 8, TV3                        NM_017522.3        −2.0    −1.9   −2.2   −2.2    −2.2
  MELK              Maternal embryonic leucine zipper kinase                                       NM_014791.2        −2.0    −2.0   −2.1   −2.3    −2.0
  GALNT10           Polypeptide *N*-acetylgalactosaminyltransferase 10, TV2                        NM_017540.3        −2.0    −1.9   −1.9   −2.0    −1.9
  CBX6              Chromobox homologue 6                                                          NM_014292.3        −2.0    −1.6   −2.3   −2.5    −2.0
  CALM1             Calmodulin 1 (phosphorylase kinase, δ)                                         NM_006888.3        −2.0    −1.7   −2.3   −2.4    −2.1
  PTTG1             Pituitary tumour-transforming 1                                                NM_004219.2        −2.1    −1.9   −2.1   −2.2    −1.8
  IL8               Interleukin 8                                                                  NM_000584.2        −2.3    −2.9   −3.0   −3.2    −2.5
  IL1RL1            Interleukin 1 receptor-like 1, TV2                                             NM_003856.2        −2.1    −2.0   −2.5   −2.5    −1.9
  FZD4              Frizzled homologue 4 (*Drosophila*)                                            NM_012193.2        −2.1    −1.6   −2.0   −2.1    −2.1
  GLCE              Glucuronic acid epimerase                                                      NM_015554.1        −2.1    −2.0   −2.5   −2.7    −2.4
  UBE2C             Ubiquitin-conjugating enzyme E2C, TV6                                          NM_181803.1        −2.1    −2.1   −2.0   −2.1    −1.9
  FAM176A           Family with sequence similarity 176, member A, TV1                             NM_001135032.1     −2.1    −2.1   −2.1   −2.2    −2.2
  ICAM2             Intercellular adhesion molecule 2, TV1                                         NM_001099786.1     −2.1    −2.1   −2.4   −2.8    −2.1
  TGM2              Transglutaminase 2, TV2                                                        NM_198951.1        −2.1    −2.0   −2.5   −2.4    −2.0
  EPHA2             EPH receptor A2                                                                NM_004431.2        −2.1    −1.7   −2.0   −2.1    −2.0
  FEN1              Flap structure-specific endonuclease 1                                         NM_004111.4        −2.1    −2.2   −2.6   −2.5    −2.2
  ATP1B1            ATPase, Na^+^/K^+^ transporting, β1 polypeptide                                NM_001677.3        −2.1    −2.0   −2.1   −2.6    −2.1
  ODZ3              Odz, odd Oz/ten-m homologue 3 (*Drosophila*)                                   NM_001080477.1     −2.1    −1.9   −2.3   −2.5    −2.1
  FILIP1L           Filamin A interacting protein 1-like, TV1                                      NM_182909.2        −2.1    −1.8   −2.1   −2.1    −1.9
  NMT2              *N*-myristoyltransferase 2                                                     NM_004808.1        −2.1    −2.1   −2.4   −2.5    −2.3
  PHACTR2           Phosphatase and actin regulator 2, TV1                                         NM_001100164.1     −2.1    −1.9   −2.2   −2.5    −1.9
  TUBA1B            Tubulin, α1b                                                                   NM_006082.2        −2.1    −1.9   −2.4   −2.1    −2.3
  C20orf127         Chromosome 20 ORF 127                                                          NM_080757.1        −2.1    −1.8   −2.7   −2.6    −2.0
  NPFFR2            Neuropeptide FF receptor 2, TV1                                                NM_004885.1        −2.1    −2.1   −2.3   −2.2    −2.3
  LIMA1             LIM domain and actin binding 1                                                 NM_016357.3        −2.2    −2.1   −2.2   −2.2    −1.9
  BASP1             Brain abundant, membrane attached signal protein 1                             NM_006317.3        −2.2    −2.0   −2.4   −2.5    −2.2
  TNFRSF12A         Tumour necrosis factor receptor superfamily, member 12A                        NM_016639.1        −2.2    −1.9   −2.6   −2.2    −2.1
  KRT7              Keratin 7                                                                      NM_005556.3        −2.2    −1.8   −2.2   −2.2    −2.0
  NCAPG             Non-SMC condensin I complex, subunit G                                         NM_022346.3        −2.2    −2.1   −2.2   −2.3    −2.4
  CCNA1             Cyclin A1                                                                      NM_003914.2        −2.2    −2.4   −2.4   −2.5    −2.5
  DIO2              Deiodinase, iodothyronine, type II, TV3                                        NM_001007023.2     −2.2    −2.0   −2.1   −1.9    −2.2
  DDAH1             Dimethylarginine dimethylaminohydrolase 1                                      NM_012137.2        −2.2    −2.1   −2.8   −2.6    −2.4
  CAV1              Caveolin 1, caveolae protein, 22 kDa                                           NM_001753.3        −2.2    −2.4   −2.4   −2.7    −2.4
  TYMS              Thymidylate synthetase                                                         NM_001071.1        −2.2    −2.3   −2.4   −2.2    −2.0
  GRB14             Growth factor receptor-bound protein 14                                        NM_004490.2        −2.2    −2.1   −2.5   −2.4    −2.1
  CAV2              Caveolin 2, TV1                                                                NM_001233.3        −2.2    −2.5   −2.3   −2.6    −2.2
  MGLL              Monoglyceride lipase (MGLL), TV1                                               NM_007283.5        −2.2    −1.8   −2.1   −2.2    −2.1
  FILIP1L           Filamin A interacting protein 1-like, TV2                                      NM_014890.2        −2.2    −1.8   −2.6   −2.5    −2.1
  CEP55             Centrosomal protein 55 kDa                                                     NM_018131.3        −2.3    −2.2   −2.2   −2.4    −2.4
  CALD1             Caldesmon 1, TV3                                                               NM_033157.2        −2.3    −2.8   −2.5   −2.3    −1.9
  UBE2C             Ubiquitin-conjugating enzyme E2C, TV3                                          NM_181800.1        −2.3    −2.4   −2.4   −2.7    −2.2
  MTE               Metallothionein E                                                              NM_175621.2        −2.3    −2.0   −3.2   −2.4    −2.5
  MCM4              Minichromosome maintenance complex component 4, TV1                            NM_005914.2        −2.3    −2.2   −2.5   −2.6    −2.3
  FABP4             Fatty acid binding protein 4, adipocyte                                        NM_001442.1        −2.3    −2.1   −2.2   −2.3    −2.5
  PLOD2             Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2, TV2                        NM_000935.2        −2.3    −2.2   −2.6   −2.8    −2.5
  TXNRD2            Thioredoxin reductase 2, nuclear gene encoding mitochondrial protein           NM_006440.3        −2.4    −2.2   −2.9   −2.8    −2.4
  LDLR              Low-density lipoprotein receptor (familial hypercholesterolaemia)              NM_000527.2        −2.4    −2.2   −2.7   −2.6    −2.5
  GIMAP4            GTPase, IMAP family member 4                                                   NM_018326.2        −2.5    −2.2   −2.6   −2.9    −2.8
  PRC1              Protein regulator of cytokinesis 1, TV2                                        NM_199413.1        −2.5    −2.1   −2.2   −2.3    −2.2
  MGLL              Monoglyceride lipase, TV1                                                      NM_007283.5        −2.5    −2.8   −2.8   −2.8    −2.4
  FKSG30            Actin-like protein                                                             NM_001017421.1     −2.5    −2.4   −2.3   −2.6    −2.2
  ALDH1A3           Aldehyde dehydrogenase 1 family, member A3                                     NM_000693.2        −2.5    −2.6   −2.6   −2.9    −2.6
  CYR61             Cysteine-rich, angiogenic inducer, 61                                          NM_001554.3        −2.5    −2.1   −2.5   −2.3    −2.7
  MAD2L1            MAD2 mitotic arrest deficient-like 1 (yeast)                                   NM_002358.2        −2.5    −2.7   −2.7   −2.6    −2.6
  CCL15             Chemokine (C-C motif) ligand 15, TV1                                           NM_032964.2        −2.5    −2.2   −2.5   −2.3    −2.3
  S1PR3             sSphingosine-1-phosphate receptor 3                                            NM_005226.2        −2.5    −2.0   −2.5   −2.4    −2.5
  C6orf105          Chromosome 6 ORF 105                                                           NM_032744.1        −2.5    −3.1   −2.7   −2.9    −2.6
  TACSTD2           Tumour-associated calcium signal transducer 2                                  NM_002353.1        −2.6    −2.2   −2.6   −3.1    −2.7
  MT1E              Metallothionein 1E                                                             NM_175617.3        −2.7    −2.2   −3.1   −2.7    −2.2
  PLOD2             Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2, TV1                        NM_182943.2        −2.7    −3.1   −2.9   −3.4    −2.7
  STC2              Stanniocalcin 2                                                                NM_003714.2        −2.7    −2.2   −3.3   −3.0    −2.9
  SDPR              Serum deprivation response (phosphatidylserine binding protein)                NM_004657.4        −2.8    −3.1   −3.2   −3.7    −3.0
  PLOD2             Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2, TV2                        NM_000935.2        −2.8    −2.4   −2.9   −3.0    −2.9
  LOC399942         Similar to tubulin α-2 chain (α-tubulin 2), TV5                                XM_934471.1        −3.0    −3.3   −2.9   −3.0    −2.8
  CXCL1             Chemokine (C-X-C motif) ligand 1                                               NM_001511.1        −3.1    −3.0   −3.3   −3.2    −2.9
  UHRF1             Ubiquitin-like with PHD and ring finger domains 1, TV1                         NM_001048201.1     −3.2    −2.7   −3.4   −3.1    −3.5
  PTGER4            Prostaglandin E receptor 4 (subtype EP4)                                       NM_000958.2        −3.3    −2.5   −3.4   −3.9    −3.4
  MGC87042          Similar to six transmembrane epithelial antigen of prostate                    XM_001128032.1     −3.4    −2.9   −3.7   −3.8    −3.4
  TOP2A             Topoisomerase (DNA) II α 170 kDa                                               NM_001067.2        −3.5    −3.3   −3.4   −3.5    −3.4
  LOC399959         Mir-100-let-7a-2 cluster host gene (nonprotein coding)                         NR_024430.1        −3.6    −3.0   −4.2   −4.0    −3.9
  STEAP1            Six transmembrane epithelial antigen of the prostate 1                         NM_012449.2        −3.6    −3.5   −3.6   −4.0    −3.7
  BMP4              Bone morphogenetic protein 4, TV3                                              NM_130851.1        −3.6    −2.8   −4.3   −3.8    −3.8
  LOC158376         Hypothetical protein                                                           XM_001129749.1     −3.9    −3.3   −3.1   −3.6    −3.6
  DKK1              Dickkopf 1 homologue (*Xenopus laevis*)                                        NM_012242.2        −5.2    −4.0   −6.2   −6.0    −5.5
  RGS4              Regulator of G-protein signalling 4                                            NM_005613.3        −7.6    −6.5   −9.9   −10.2   −9.0

![Global changes in gene expression between normal and micropatterned HCAECs. (A) Hierarchical clustering and heatmap representation of the 361 genes differentially expressed in the shape-restricted cells compared to the nonrestricted controls. The colour-coded scale (blue--green = down-regulation; orange--red = up-regulation) for the normalized fold changes is indicated at the bottom. Details for the regulated genes are provided in [Fig. 2](#fig02){ref-type="fig"} and are publically available via the Gene Expression Omnibus (accession number GSE43349). Only genes with expression levels regulated above a two-fold change (*P* \< 0.05) compared to the nonrestricted cells are shown. (B, C) Profile plots correlating the gene expression levels based on normalized signal intensities of probe sets between nonrestricted and micropatterned HCAECs under (B) standard growth conditions or (C) after 48 h of serum starvation. (D) Profile plot comparison of the gene expression intensity changes only between each micropattern condition.](febs-280-4474-f5){#fig05}

Although seeding density was controlled in these experiments to minimize cell-to-cell contact (particularly in the control samples where cellular interactions are possible), it is probable that the use of rich growth media encourages the proliferation of the nonrestricted cells but, because shape restriction has been shown to inhibit proliferation [@b8], is unable to do so in the shape-restricted cells. This could potentially induce bias in the interpretation of the data from the unrestricted HCAECs as a result of differences in cell cycle progression or cell-to-cell contacts that arise between the mother and daughter cells following mitosis. To address this potential concern, we performed the same micropatterning experiment as described above, except the cells in both the nonrestricted and shape-restricted conditions were serum starved for 48 h before RNA collection to block cell proliferation, thus eliminating variables such as cell-to-cell contact, cell cycle differences, etc. A comparison of the profile plots of nonrestricted versus shape-restricted HCAECs grown in standard growth conditions or subsequent to serum starvation yielded similar results, indicating that, regardless of growth conditions, proliferation or cell-to-cell contact, morphological restriction induced significant changes in the global gene expression profiles ([Fig. 5](#fig05){ref-type="fig"}C). The complete microarray data set for the serum starvation experiment is publically available via the Gene Expression Omnibus (accession number GSE44168).

Previous data collected from mesenchymal progenitor cells conforming to micropatterns that induced the cells to form obtuse versus acute morphological angles suggested that cell morphology controls lineage specification. Although endothelial cells are terminally differentiated, we aimed to determine whether such distinct morphological as well as polarity changes might influence the endothelial transcriptome. By excluding the nonrestricted conditions from the analysis, we compared the gene expression changes between only the micropatterned endothelial cells adhering to cross-bow, disc, H, L and Y shapes to examine whether distinct cellular morphology can affect endothelial gene expression patterns. As shown in [Fig. 5](#fig05){ref-type="fig"}B,C and [Table 2](#tbl2){ref-type="table"}, gene expression changes did not significantly vary based on the particular shape, actin patterning or polarity to which the cells conformed. Indeed, statistical analysis of the genomic data set failed to reveal a single two-fold or greater (*P* \< 0.05) alteration in gene expression between any of the cell shapes. These data suggest that, unlike mesenchymal stem cells whose phenotype can be modulated by cellular angularity, endothelial cells grown under these unique geometric constraints do not differ in their global gene expression patterns. Cumulatively, our data indicates that morphological constraint, rather than cellular angularity and polarity, alter the global transcriptome under these conditions.

Pathway analysis of the morphology induced transcriptome changes
----------------------------------------------------------------

We next implemented a systems level approach to understand how geometric constraint may affect the overall cellular phenotype. Our initial analysis reported above included two-fold or greater changes in gene expression, yet, for this network analysis, we broadened our microarray data set (from the standard growth condition experiment) to include the 1.4-fold or greater statistically relevant (*P* \< 0.05) changes in gene expression. This cut-off was selected not only to refrain from limiting our network analysis to solely the highest expression changes, but also to take into account transcriptional changes that were less pronounced but still relevant with regard to modulating cellular physiology. This resulted in ∼ 8% of the human genome experiencing changes in gene expression (642 up-regulated genes and 1218 down-regulated genes). We then performed [metacore]{.smallcaps} pathway analysis of these gene expression changes to predict significant alterations in major cellular processes, including cell cycle regulation (*P* \< 3.3 × 10^−8^) ([Table 3](#tbl3){ref-type="table"}), cytoskeletal dynamics and cell adhesion (*P* \< 4.2 × 10^−5^) ([Table 4](#tbl4){ref-type="table"}), glycolysis/gluconeogenesis (*P* \< 2.7 × 10^−4^) ([Table 5](#tbl5){ref-type="table"}), TGFβ signalling (*P* \< 1.6 × 10^−3^) ([Table 6](#tbl6){ref-type="table"}) and wingless-type (Wnt) signalling (*P* \< 1.6 × 10^−3^) ([Table 7](#tbl7){ref-type="table"}). Because TGFβ signalling has been shown to play a major role in arteriosclerotic disease progression, we confirmed our microarray data utilizing quantitative PCR to detect the shape-induced alterations in mRNA expression levels of the TGFβ signalling genes *SMAD6*, *SMAD7* and *TGFB2*, as well as several genes reportedly involved in the atherosclerotic process, including *LPL*, *MMP1*, *KDR*, *ITGA2*, *ACE*, *BIRC3*, *IL1R1*, *ICAM1*, *HEY1*, *BCL2*, *CSF2*, *APOE*, *PDGFB*, *BCL2A1*, *CCL2* and *LDLR* ([Fig. 6](#fig06){ref-type="fig"}).

###### 

Fold changes in mRNA expression levels of genes involved in cell cycle progression

  Gene     X-bow   Disc   H      L      Y
  -------- ------- ------ ------ ------ ------
  H1F0     1.6     1.4    1.5    1.5    1.8
  TUBB6    −1.3    −1.4   −1.4   −1.6   −1.4
  CCT2     −1.4    −1.3   −1.5   −1.6   −1.4
  TUBA1C   −1.4    −1.3   −1.7   −1.5   −1.5
  DYNLL1   −1.4    −1.4   −1.6   −1.7   −1.3
  H3F3B    −1.4    −1.4   −1.8   −1.7   −1.5
  TUBA1A   −1.5    −1.4   −1.6   −1.6   −1.7
  RBX1     −1.5    −1.4   −1.5   −1.8   −1.5
  PCNA     −1.5    −1.6   −1.8   −1.8   −1.5
  TCP1     −1.5    −2.1   −1.4   −1.8   −1.4
  CCT6A    −1.5    −2.1   −1.5   −1.9   −1.4
  BUB3     −1.5    −1.4   −1.5   −1.5   −1.4
  CSE1L    −1.5    −1.2   −1.5   −1.7   −1.4
  TUBB2A   −1.5    −1.5   −1.7   −1.5   −1.6
  CDK6     −1.6    −1.3   −1.5   −1.5   −1.6
  PPP2CA   −1.6    −1.6   −1.8   −1.9   −1.7
  CKS1B    −1.6    −1.6   −1.7   −1.8   −1.6
  AURKA    −1.7    −1.7   −2.1   −1.9   −1.9
  TFDP1    −1.7    −1.6   −1.7   −1.9   −1.7
  CCND2    −1.7    −1.7   −2.0   −2.2   −2.0
  CCND3    −1.8    −1.6   −2.0   −2.0   −2.0
  CDC20    −1.8    −1.9   −2.1   −1.8   −2.0
  CCNB2    −1.9    −1.8   −1.8   −1.7   −1.9
  PTTG1    −1.9    −2.2   −2.1   −2.1   −1.8
  CCNA2    −2.0    −1.9   −2.1   −1.9   −1.9
  RAN      −2.0    −2.2   −2.3   −2.4   −2.0
  TUBA1B   −2.1    −1.9   −2.4   −2.1   −2.3
  NCAPG    −2.2    −2.1   −2.2   −2.3   −2.4
  CCNA1    −2.2    −2.4   −2.4   −2.5   −2.5
  MAD2L1   −2.5    −2.7   −2.7   −2.6   −2.6
  TOP2A    −3.5    −3.3   −3.4   −3.5   −3.4

###### 

Fold changes in mRNA expression levels of genes involved in cytoskeletal dynamics and cell adhesion

  Gene      X-bow   Disc   H      L      Y
  --------- ------- ------ ------ ------ ------
  SYNM      2.4     2.1    2.0    2.2    2.4
  MMP10     2.0     2.0    1.6    1.4    1.7
  MMP1      1.7     1.9    1.3    1.4    1.3
  ITGB4     1.7     1.8    1.7    1.7    1.6
  JUN       1.6     1.5    1.4    1.4    1.5
  RPS6KA5   1.6     1.4    1.5    1.4    1.8
  AXIN2     1.5     1.5    1.4    1.4    1.5
  MYLK      1.5     1.3    1.5    1.3    1.4
  CSNK2A2   1.5     1.5    1.3    1.2    1.4
  TUBB6     −1.3    −1.4   −1.4   −1.6   −1.4
  CD44      −1.4    −1.6   −1.3   −1.7   −1.4
  TUBA1C    −1.4    −1.3   −1.7   −1.5   −1.5
  FLOT2     −1.4    −1.3   −1.6   −1.7   −1.5
  MYL9      −1.4    −1.7   −1.5   −1.6   −1.3
  TUBA1A    −1.5    −1.4   −1.6   −1.6   −1.7
  EIF4G2    −1.5    −2.2   −1.5   −2.0   −1.5
  SHC1      −1.5    −1.4   −1.1   −1.3   −1.4
  ROCK2     −1.5    −1.2   −1.4   −1.6   −1.5
  VCL       −1.5    −1.6   −1.4   −1.7   −1.6
  ZYX       −1.5    −1.4   −2.0   −1.7   −1.7
  TUBB2A    −1.5    −1.5   −1.7   −1.5   −1.6
  ACTN4     −1.6    −1.3   −1.8   −1.7   −1.6
  CAV2      −1.6    −1.5   −1.8   −1.8   −1.7
  NES       −1.7    −1.5   −1.7   −1.8   −1.5
  ACTR2     −1.7    −1.5   −1.6   −1.8   −1.5
  GNG12     −1.7    −2.5   −1.6   −2.1   −1.6
  TUBB6     −1.7    −2.2   −1.6   −1.8   −1.6
  TUBG1     −1.7    −1.4   −1.6   −1.9   −1.6
  IL8       −1.8    −1.9   −2.1   −2.0   −1.7
  TUBA1A    −1.9    −2.0   −1.8   −2.3   −1.9
  TJP2      −2.0    −1.7   −1.6   −1.7   −1.7
  TUBA1B    −2.1    −1.9   −2.4   −2.1   −2.3
  CAV1      −2.2    −2.4   −2.4   −2.7   −2.4
  CXCL1     −3.1    −3.0   −3.3   −3.2   −2.9

###### 

Fold changes in mRNA expression levels of genes involved in glycolysis and gluconeogenesis

  Gene    X-bow   Disc   H      L      Y
  ------- ------- ------ ------ ------ ------
  ENO1    −1.4    −1.2   −1.6   −1.5   −1.4
  MDH1    −1.5    −1.5   −1.6   −1.8   −1.4
  PGK1    −1.5    −1.5   −1.6   −1.9   −1.9
  PGAM1   −1.6    −1.7   −1.6   −1.8   −1.5
  TPI1    −1.6    −1.7   −1.5   −1.7   −1.5
  LDHA    −1.6    −1.6   −1.9   −2.0   −1.8
  PGAM4   −1.7    −1.8   −1.6   −1.9   −1.7

###### 

Fold changes in mRNA expression levels of genes involved in TGFβ signalling

  Gene      X-bow   Disc   H      L      Y
  --------- ------- ------ ------ ------ ------
  HEY1      3.1     2.7    2.7    2.7    3.1
  SMAD7     2.6     2.4    2.5    2.7    2.6
  GDF15     2.1     2.2    2.0    1.9    2.1
  BMP2      2.1     2.0    1.9    1.7    2.0
  SMAD6     1.9     2.0    1.8    1.8    2.0
  BMPR2     1.6     1.6    1.4    1.4    1.6
  GADD45B   1.4     1.4    1.2    1.4    1.7
  FKBP1A    −1.4    −1.6   −1.4   −1.8   −1.3
  TGFB2     −1.5    −1.5   −1.4   −1.5   −1.5
  SHC1      −1.5    −1.4   −1.1   −1.3   −1.4
  SNAI2     −1.7    −1.6   −1.7   −1.8   −1.7
  TGFBR2    −1.5    −1.4   −1.6   −1.9   −1.6
  EDN1      −1.7    −1.7   −2.0   −1.7   −1.7
  BMP4      −1.7    −1.7   −1.6   −1.5   −1.8
  CAV1      −2.0    −2.0   −2.3   −2.3   −1.9

###### 

Fold changes in mRNA expression levels of genes involved in Wnt signalling

  Gene     X-bow   Disc   H      L      Y
  -------- ------- ------ ------ ------ ------
  TCF4     1.7     1.8    1.5    1.6    1.7
  RUVBL2   −1.4    −1.4   −1.6   −1.6   −1.2
  SNAI2    −1.7    −1.6   −1.7   −1.8   −1.7
  FZD4     −2.1    −1.6   −2.0   −2.1   −2.1
  DKK1     −5.2    −4.0   −6.2   −6.0   −5.5

![Quantitative PCR confirmation of microarray data. Confirmatory quantitative PCR was performed on 19 genes whose expression was shown to be altered in the microarray data. Relative quantification (RQ) values are shown for each gene expression change. cDNA was obtained from normal and crossbow shape cells grown under standard culture conditions.](febs-280-4474-f6){#fig06}

Discussion
==========

The interplay between the physical, chemical and biological cues to which cells are constantly exposed modulates processes ranging from those as broad as cellular lineage determination to those as subtle as the functional nuances between two adjacent cells. Despite the number of studies addressing this area of research, the molecular mechanisms by which these cues synergize is largely unknown. It has been reported that cellular morphology and cytoskeletal angularity greatly influence progenitor lineage specification [@b14] and that changes in cell shape influence chromatin condensation via nuclear deformation [@b25]. In the present study, we aimed to determine whether morphological changes in coronary artery endothelial cells could affect the global patterns of gene expression. Understanding how cell shape change affects the coronary artery endothelial cell transcriptome may allow us to better understand the molecular aberrations that underlie coronary artery disease. The present study made use of micropatterned growth substrates that force cells to conform to precise geometric shapes. Although micropatterned cell growth has been utilized in a limited number of studies, there is little evidence that such techniques consistently lead to morphological and cytoskeletal patterns that are highly reproducible and truly unique between different micropatterns. We utilized pattern recognition algorithms and statistical analysis to confirm that cells conforming to the crossbow, disk, H, L or Y shapes had truly reproducible cellular morphology and cytoskeletal architecture unique for each cell shape adopted. Given that most analysis of cytoskeletal organization in the available literature is qualitative in nature, this algorithm can be extensively used in the future to provide quantitative interpretations of the differences in both static (as we have analyzed) and dynamic cytoskeletal structures between two or more treatment groups.

Upon demonstrating the reproducibility and applicability of micropatterns to control cellular morphology, we utilized microarray technology to analyze how morphological restriction and unique cellular morphologies affect the HCAEC transcriptome. Our data indicate that morphological restriction (i.e. ability of the cell to spread) is a major regulator of endothelial gene expression patterns, as demonstrated by large-scale changes in gene expression after morphological restriction of HCAECs. Our data indicate that morphological restriction via micropattern adherence greatly increases the incidence of nuclear deformation in HCAECs. Given that large-scale cell shape changes results in a drastic condensation of chromatin as a result of lateral compressive force-induced nuclear orientation shifts and deformation [@b25], it is possible that restricting cell spreading affects the dynamic genome architecture in the nuclear space, thus regulating gene expression by modulating the geometric constraints that regulate dynamic chromatin positioning. We suspect that shape-induced gene expression changes are more complex than simply a consequence of nuclear deformation given that the transcriptome between each of the micropatterned shapes was remarkably similar, whereas the level of nuclear deformation varied drastically between the individual micropatterns. Indeed, although distinct cell shapes and cytoskeletal patterning have been reported to regulate mesenchymal progenitor lineage determination and endothelial cell chromatin condensation [@b14],[@b25], we were very surprised to discover that shape induced gene expression patterns were remarkably constant across all altered cellular morphologies tested relative to each other. Moreover, considering a recent study suggesting that cell geometry does not regulate the adipogenic differentiation of mesenchymal stem cells [@b15], further follow-up studies are needed to determine how cellular geometry affects the phenotype of different cell types. Our data do not necessarily contradict the report of shape-induced differentiation in mesenchymal progenitor cells [@b14] but, instead, suggest that there are varying levels of responsiveness to morphology driven cellular outputs between different cell types (mesenchymal progenitor versus coronary artery endothelial cells). Cummulatively, our data suggest that the ability of HCAECs to spread (but not necessarily their particular morphology) dictates their genomics patterns. These data build on and corroborate the findings reported in earlier work indicating that endothelial spreading regulates cell fate decisions between proliferation and death [@b8],[@b11].

Bioinformatics analysis of the microarray data revealed that the largest functional groupings of genes whose expression was altered upon morphological restriction were those involved in cell cycle regulation (30 genes) and cytoskeletal dynamics/cell adhesion (34 genes). Within the identified cell cycle regulators, a number of genes were strongly involved in spindle assembly, cell cycle phase transition, nucleocytoplasmic transport of cyclins and cyclin-dependent kinases, and chromosome condensation. With the exception of one gene (*H1F0*, which encodes for a histone protein), the expression the identified cell cycle-related genes was down-regulated, including the major cell cycle promoters *CDK6*, *CCNA1*, *CCNB2*, *CCND2* and *CCND3*. Considering the previously proposed impact of cell shape on chromosome condensation, we were intrigued at the down-regulation of genes involved in DNA accessibility, including condensin (*NCAPG*), topoisomerase II α (*TOP2A*), histone H3 (*H3F3B*) and histone H1 (*H1F0*). These particular changes could have a role in modulating global gene expression, lineage specification and the cellular physiology of endothelial cells and their progenitors. In mesenchymal progenitor cells, it has been reported that shape-induced contraction enhances c-Jun N-terminal kinase and extracellular-related kinase 1/2 activity in conjunction with wingless-type signalling [@b14]. Pathway analysis of the microarray data from the shape confirmed that HCAECs revealed shape-induced alterations in the expression of genes involved in Wnt signalling (up-regulation of *TCF4* and down-regulation of *RUVBL2*, *SNAI2*, *FZD4* and *DKK1*) and an up-regulation in *JUN* expression, indicating that similar changes in these signalling pathways likely occur when the endothelial cell morphology is altered. Additionally, the expression of several genes encoding members of the TGFβ signalling cascades was altered upon changes in HCAEC shape, including the ligands *BMP2*, *BMP4* and *TGFB2*, the type II receptor *BMPR2*, and the signalling effectors *SMAD6* and *SMAD7*. Given that aberrant TGFβ signalling is critically implicated in the progression of coronary artery disease and arteriosclerosis [@b31], it is possible that endothelial cell shape changes could initiate and/or exacerbate disease progression via alterations in the expression of key genes involved in these processes.

Materials and methods
=====================

Cell culture and treatments
---------------------------

Primary cultures of human coronary artery endothelial cells (HCAECs; \< 5 passages; \#PCS-100-020; ATCC, Manassas, VA, USA) were cultured in vascular cell basal media (\#PCS-100-030; ATCC) supplemented with 0.2% bovine brain extract, 5 ng·mL^−1^ human epidermal growth factor, 10 m[m l]{.smallcaps}-glutamine, 0.75 units·mL^−1^ heparin sulfate, 1 μg·mL^−1^ hydrocortisone, 50 μg·mL^−1^ ascorbic acid, 2% fetal bovine serum and pen/strep. For serum starvation experiments, HCAECs were cultured in vascular cell basal media (\#PCS-100-030; ATCC) supplemented with 10 m[m l]{.smallcaps}-glutamine, 0.75 units·mL^−1^ heparin sulfate, 1 μg·mL^−1^ hydrocortisone, 50 μg·mL^−1^ ascorbic acid and pen/strep for 48 h before RNA collection. For cell shape patterning, collagen I-coated coverslips and 96-well plates with micropatterns surrounded by non-adhesive surfaces (Cytoo Inc., Grenoble, France) were seeded with ∼ 5000 or 50 000 HCAECs per well and coverslip, respectively, in accordance with the manufacturer's instructions. For the control, cells were seeded at low density approximately equal to that seen in the micropatterned conditions (to minimize cell-to-cell contacts) on collagen I-coated coverslips and 96-well plates. For all experiments, disc, crossbow, H, Y, and L adhesive micropatterns (1600 μm^2^) plus controls were contained on the same chip or plate to reduce experimental variability.

Immunofluorescence
------------------

Micropatterned coverslips (Cytoo Inc.) were fixed in fresh 4% paraformaldehyde, blocked in 5% BSA plus 0.5% Tween-20, and incubated with 1 : 200 phospho-FAK (\#3283; Cell Signaling, Danvers, MA, USA) antibody, 1 : 350 rhodamine-conjugated phalloidin (Cytoskeleton Inc., Denver, CO, USA) and 1 : 1000 DAPI. Anti-phospho-FAK was labelled with a FITC-conjugated secondary antibody and immunofluorescent images were captured in 0.1-μm Z-stacks using a C2SI scanning laser confocal microscope (Nikon, Tokyo, Japan). Images were equivalently processed in [nikon elements]{.smallcaps} 3.2, surface rendering images were obtained using [imaris]{.smallcaps}, version 6.0 (Bitplane AG, Zurich, Switzerland) and three-dimensional deconvolution was performed using Autoquant X3 (Media Cybernetics, Inc., Bethesda, MD, USA).

Quantification of actin fibre length
------------------------------------

For each analysis, 11--14 images of each shape from the actin immunofluorescent images were utilized. Images were initially preprocessed by implementing contrast-limited adaptive histogram equalization, which enhances the contrast of the image in small regions rather than as a whole [@b32] ([Fig. 2](#fig02){ref-type="fig"}B). Images are rotated to have consistent orientation of the micropattern for all analyses. For automatic detection of actin fibres, we utilized the [fiberscore]{.smallcaps} algorithm reported by Lichtenstein *et al*. [@b29], which bases the segmentation of fibres on the probability that a pixel neighbourhood belongs to a fibre. The output of the [fiberscore]{.smallcaps} algorithm comprises a correlation image ([Fig. 2](#fig02){ref-type="fig"}C), which indicates pixels with higher probability of belonging to a fibre, and an orientation image ([Fig. 2](#fig02){ref-type="fig"}D), which indicates the orientation of the fibre at each pixel location. To remove fibres from the resulting [fiberscore]{.smallcaps} output that are less correlated than other image regions, we performed a two-step post processing method: (a) remove pixels with correlation values below a predetermined threshold ([Fig. 2](#fig02){ref-type="fig"}E) and (b) skeletonize the fibre structures with combinations of the basic morphological operations erosion and opening [@b32] ([Fig. 2](#fig02){ref-type="fig"}F). The skeletonization process removes repetitive information within each detected fibre. Individual and median fibre lengths were obtained by measuring the processed fibre length in the skeletonized images.

Quantification of actin fibre orientation
-----------------------------------------

For analysis of actin fibre orientation, each image was divided into nine separate tiles in the form of a 3 × 3 grid, thus providing information on where in the cell certain distributions of angles occur. Tiling allows for the option of local subcellular measurements of actin orientation, at the same time as gathering all information in the tiles provides a measure of the entire cell. For quantitative analysis of the 3 × 3 tiling, we implemented the two-sample KS test [@b30] to compare cell images within a single shape in terms of overall fibre orientation distributions. We used the KS test in two different methods to calculate the amount of difference between the distributions of fibre angles. In the first method, we compared the entire individual image to the cumulative tiling, providing a measure of the overall global difference in fibre distributions. The second method compared an individual image with the cumulative shape image on a tile-by-tile basis, providing a local measure of the difference between individual cell distributions and the cumulative distributions. This tile-by-tile comparison is used to pinpoint similar regions between cell shapes that can be result in less uniqueness in global shape comparisons. Both methods count the number of null hypothesis rejections (at a significance level of 0.05) and normalize according to the number of KS tests.

Gene expression analysis
------------------------

For each shape tested, as well as the nonrestricted controls, ∼ 5000 HCAECs were grown in each well of a 96-well micropatterned plate. This was replicated in 16 independent wells per shape to minimize experimental error. Total RNA for each shape was isolated using the Purelink RNA Micro kit (Invitrogen, Grand Island, NY, USA) after 24 h of the cells adhering to the substrate. The isolated RNA from the replicates (5000 cells per shape multiplied by 16 independent replicates) were pooled, amplified and biotin-labelled using an Illumina TotalPrep RNA Amplification Kit (Illumina, San Diego, CA, USA). Some 750 ng of biotinylated aRNA was then briefly heat-denatured and loaded onto expression arrays to hybridize overnight. Following hybridization, arrays were labelled with Cy3-streptavidin and imaged using the Illumina ISCAN. Intensity values were transferred to [genespring gx]{.smallcaps} software (Agilent Technologies Inc., Santa Clara, CA, USA) and data were filtered based on the quality of each call. Statistical relevance was determined using analysis of variance with a Benjamini Hochberg false discovery rate multiple testing correction (*P* \< 0.05). Data were then limited by fold change analysis to statistically relevant data points demonstrating a two-fold or greater change in expression. Omics pathway analysis was performed with [metacore]{.smallcaps} software (GeneGo, San Diego, CA, USA). Microarray data were publically deposited in Gene Expression Omnibus (standard growth conditions = accession number GSE43349; Serum starvation conditions = accession number GSE44168). For confirmation of microarray results, RNA from normal- and crossbow-shaped cells was converted to cDNA using the Verso cDNA kit (Thermo-Scientific, Waltham, MA, USA) and quantitative PCR was performed using SYBR Green probes (Invitrogen) with an ABI7900HT real-time PCR instrument (Invitrogen).
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DAPI

:   4′,6-diamidino-2-phenylindole

HCAEC

:   human coronary artery endothelial cell

KS

:   Kolmogorov--Smirnov

TGF

:   transforming growth factor

Wnt

:   wingless-type
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